Pharmakon Advisors
North America, New York, United States, New York
Description
Pharmakon Advisors is a New York-based investment company that offers financing solutions to commercial stage, biotechnology companies.
Investor Profile
Pharmakon Advisors has backed more than 18 startups, with 2 new investments in the last 12 months alone. The firm has led 11 rounds, about 61% of its total and boasts 15 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Debt, Series A, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, Norway.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Led 2 rounds in the past year.
Stage Focus
- Post Ipo Debt (83%)
- Series A (6%)
- Post Ipo Equity (6%)
- Debt Financing (6%)
Country Focus
- United States (94%)
- Norway (6%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Therapeutics
- Biopharma
- Life Science
- Oncology
- Medical Device
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Pharmakon Advisors frequently co-invest with?
Which angels does Pharmakon Advisors often collaborate with?
What are some of recent deals done by Pharmakon Advisors?
Find More Investors Like Pharmakon Advisors
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
